this post was submitted on 20 Aug 2026
22 points (84.4% liked)

Feminism

1624 readers
29 users here now

Welcome to the feminism community on Lemmy.World!

Rules:

  1. This is a feminist community, meant for discussing issues around equality and gender. Disagreement is acceptable but anti-feminist statements are not. Similarly, TERF-aligned comments, including anti-trans or other anti-LGBTQ+ sentiments are not allowed. This does not preclude debunking anti-feminist talking points.
  2. Posts must be related to feminism, gender issues, or related content. Topics can include current issues/news, historical topics, personal questions/thoughts, or discussion threads. If you are unsure if your post is on-topic, feel free to message the mods before posting.
  3. Memes and humor are allowed but should not be excessively posted.
  4. No hate speech, slurs, celebrating death, advocating violence, or abusive language. This will result in a ban. Utilizing such language in your username will also result in a ban.
  5. Follow site-wide rules.

founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] DrBob@lemmy.ca 2 points 2 weeks ago (1 children)

These are valid points, and I must stress that CVD is nowhere close to being in my wheelhouse - I can overstep here easily. From the bit that I know about prospective trials of those sorts, participation is often driven by a single factor; physician links to the study which biases towards university affiliated clinics. I have no doubt that impacts patient recruitment.

As the article states there has been a directive since the 1990s for clinical trials to reflect the racial and ethnic proportions of the real-world populations impacted by the condition. That has met with some (limited?) success. The guidance has strengthened in the last few years.

These issues are well worth discussing. My point was that the article seems to be focused on awareness raising with a confrontational edge. The research field is well aware of these biases and has been taking steps to correct them. I didn't see that sort of nuance in the article.

[–] velma@sh.itjust.works 2 points 2 weeks ago (1 children)

A congressionally mandated National Academies analysis found that just 8.8% of NIH grant spending from 2013 through 2023 focused on women’s health research.

And that sliver got even smaller: It fell from 9.7% in 2013 to 7.9% in 2023 — even as the NIH’s overall grant funding grew.

Is it getting better?

[–] DrBob@lemmy.ca 1 points 2 weeks ago (1 children)

I don't know what's captured in the category. I'm not in the USA anymore so I've been out of touch with NIH for more than a decade.

[–] velma@sh.itjust.works 2 points 2 weeks ago (1 children)

I was simply pointing out that this article that we’re discussing specifically mentions that funding has been going down, not increasing.

[–] DrBob@lemmy.ca 1 points 2 weeks ago (1 children)

Funding for everything at NIH has been going down. It is not a great time to be in medical research, particularly in public health.

[–] velma@sh.itjust.works 3 points 2 weeks ago (1 children)

If you read the article, you'll know that the NIH's overall grant funding grew while women's health research funding shrank.

It's in the quoted section in my comment above.

[–] DrBob@lemmy.ca 1 points 2 weeks ago (1 children)

I read the article and missed that part. I'll give it another look.

[–] velma@sh.itjust.works 2 points 2 weeks ago

A congressionally mandated National Academies analysis found that just 8.8% of NIH grant spending from 2013 through 2023 focused on women’s health research.

And that sliver got even smaller: It fell from 9.7% in 2013 to 7.9% in 2023 — even as the NIH’s overall grant funding grew.